Literature DB >> 10373186

Audit of use of ACE inhibitors and monitoring in general practice. Guidelines on monitoring, on their own, are not sufficient.

N Freemantle, J Mason, M Eccles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10373186      PMCID： PMC1116036          DOI： 10.1136/bmj.318.7199.1697

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.

Authors:  M Lough; J Cleland; J Langan; A Cowley; A Wade
Journal:  BMJ       Date:  1998-11-14

Review 2.  North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-05-02

Review 3.  Renal failure related to angiotensin-converting enzyme inhibitors.

Authors:  S C Textor
Journal:  Semin Nephrol       Date:  1997-01       Impact factor: 5.299

4.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney.

Authors:  D E Hricik; P J Browning; R Kopelman; W E Goorno; N E Madias; V J Dzau
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

5.  Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure.

Authors:  P A Kalra; M Kumwenda; P MacDowall; M O Roland
Journal:  BMJ       Date:  1999-01-23
  5 in total
  2 in total

1.  Standardised monitoring of patients on long-term medication in primary care.

Authors:  Alison Rodway; J A Fleetwood; M F Laker; Sandra Knowles; P W Sanderson; M E Scott
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

2.  Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease.

Authors:  B Unal; J A Critchley; S Capewell
Journal:  J Epidemiol Community Health       Date:  2003-07       Impact factor: 3.710
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.